Leithner et al. showed that one of the isoforms of this enzyme, PCK2 (or PEPCK2), was shown to be actively expressed by lung cancer cells and that expression levels were enhanced under low-glucose conditions [39]. This evidence concerns the gene PCK2 and lung cancer.